Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function

被引:101
作者
Lysaker, PH
Bell, MD
Bryson, G
Kaplan, E
机构
[1] Hamilton Ctr Inc, Linton, IN 47441 USA
[2] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA
[3] W Haven VA Med Ctr, New Haven, CT USA
[4] Yale Univ, Sch Med, New Haven, CT USA
关键词
schizophrenia; schizoaffective disorder; neurocognitive impairment; executive function; Wisconsin Card Sorting Test;
D O I
10.1111/j.1600-0447.1998.tb10003.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
It remains unclear how impaired insight and neurocognitive impairment are related to one another in schizophrenia. In order to examine this relationship, subjects with schizophrenia or schizoaffective disorder were classified as having 'impaired' (n = 38) or 'unimpaired' (n = 43) insight based on their insight rating on the Positive and Negative Syndrome Scale (PANSS). Their performance on neuropsychological tests of global function, executive function, memory and vigilance was then compared. Multivariate analyses followed by Scheffe tests indicated that subjects with impaired insight performed less well on the Wisconsin Card Sorting Test, demonstrating poorer abstract flexibility and heightened perseveration. No differences were found between the groups with regard to global cognitive function, memory or vigilance. This suggests that insight is closely linked to deficits in executive function, and that it may be associated with the compromise of frontal lobe function.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 34 条
[1]   AWARENESS OF ILLNESS IN SCHIZOPHRENIA [J].
AMADOR, XF ;
STRAUSS, DH ;
YALE, SA ;
GORMAN, JM .
SCHIZOPHRENIA BULLETIN, 1991, 17 (01) :113-132
[2]  
AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826
[3]  
Amador XF, 1996, AM J PSYCHIAT, V153, P1185
[4]   CLINICAL SYMPTOMATOLOGY AND DRUG COMPLIANCE IN SCHIZOPHRENIC-PATIENTS [J].
BARTKO, G ;
HERCZEG, I ;
ZADOR, G .
ACTA PSYCHIATRICA SCANDINAVICA, 1988, 77 (01) :74-76
[5]   THE POSITIVE AND NEGATIVE SYNDROME SCALE AND THE BRIEF PSYCHIATRIC RATING-SCALE - RELIABILITY, COMPARABILITY, AND PREDICTIVE-VALIDITY [J].
BELL, M ;
MILSTEIN, R ;
BEAMGOULET, J ;
LYSAKER, P ;
CICCHETTI, D .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1992, 180 (11) :723-728
[6]   CONCURRENT VALIDITY OF THE COGNITIVE COMPONENT OF SCHIZOPHRENIA - RELATIONSHIP OF PANSS SCORES TO NEUROPSYCHOLOGICAL ASSESSMENTS [J].
BELL, MD ;
LYSAKER, PH ;
MILSTEIN, RM ;
BEAMGOULET, JL .
PSYCHIATRY RESEARCH, 1994, 54 (01) :51-58
[7]   5-COMPONENT MODEL OF SCHIZOPHRENIA - ASSESSING THE FACTORIAL INVARIANCE OF THE POSITIVE AND NEGATIVE SYNDROME SCALE [J].
BELL, MD ;
LYSAKER, PH ;
BEAMGOULET, JL ;
MILSTEIN, RM ;
LINDENMAYER, JP .
PSYCHIATRY RESEARCH, 1994, 52 (03) :295-303
[8]  
BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891
[9]  
Brandt J., 1991, The Clinical Neuropsychologist, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]
[10]  
CARPENTER WT, 1976, ARCH GEN PSYCHIAT, V33, P508